Laboratorios Farmaceuticos Rovi Stock Performance
| LABFF Stock | USD 90.61 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Laboratorios Farmaceuticos are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Laboratorios Farmaceuticos Rovi has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Laboratorios Farmaceuticos is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 53.2 M | |
| Total Cashflows From Investing Activities | -40.8 M |
Laboratorios |
Laboratorios Farmaceuticos Relative Risk vs. Return Landscape
If you would invest 9,061 in Laboratorios Farmaceuticos Rovi on November 9, 2025 and sell it today you would earn a total of 0.00 from holding Laboratorios Farmaceuticos Rovi or generate 0.0% return on investment over 90 days. Laboratorios Farmaceuticos Rovi is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Laboratorios, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Laboratorios Farmaceuticos Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Laboratorios Farmaceuticos for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Laboratorios Farmaceuticos can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Laboratorios Farmaceuticos generated a negative expected return over the last 90 days | |
| About 60.0% of the company outstanding shares are owned by corporate insiders |
Laboratorios Farmaceuticos Fundamentals Growth
Laboratorios Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Laboratorios Farmaceuticos, and Laboratorios Farmaceuticos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratorios Pink Sheet performance.
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Price To Earning | 15.16 X | |||
| Price To Book | 6.51 X | |||
| Price To Sales | 3.45 X | |||
| Revenue | 648.68 M | |||
| EBITDA | 204.66 M | |||
| Cash And Equivalents | 158.94 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.37 X | |||
| Total Asset | 732.68 M | |||
About Laboratorios Farmaceuticos Performance
By analyzing Laboratorios Farmaceuticos' fundamental ratios, stakeholders can gain valuable insights into Laboratorios Farmaceuticos' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratorios Farmaceuticos has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratorios Farmaceuticos has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Laboratorios Farmaceuticos operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1852 people.Things to note about Laboratorios Farmaceuticos performance evaluation
Checking the ongoing alerts about Laboratorios Farmaceuticos for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Laboratorios Farmaceuticos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratorios Farmaceuticos generated a negative expected return over the last 90 days | |
| About 60.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Laboratorios Farmaceuticos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratorios Farmaceuticos' stock is overvalued or undervalued compared to its peers.
- Examining Laboratorios Farmaceuticos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratorios Farmaceuticos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratorios Farmaceuticos' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratorios Farmaceuticos' pink sheet. These opinions can provide insight into Laboratorios Farmaceuticos' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratorios Pink Sheet analysis
When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |